ThomasStarck (Talk | contribs) |
ThomasStarck (Talk | contribs) |
||
Line 249: | Line 249: | ||
<div class="block full"> | <div class="block full"> | ||
<p>The synthesis of NGF and TEV is placed under the control of Plac promoter. The promoter can be in two different states: occupied (Po) by the repressor lacI, preventing RNA polymerase from binding and thus preventing transcription, or free (Pf) thanks to IPTG binding to the repressor. We assume that one IPTG molecule binds with one repressor molecule, freeing the promoter and restoring RNA polymerase binding capacity. The real mechanism of promoter Plac is more complex, as described in [1], but this simplification is sufficient for our model.</p> | <p>The synthesis of NGF and TEV is placed under the control of Plac promoter. The promoter can be in two different states: occupied (Po) by the repressor lacI, preventing RNA polymerase from binding and thus preventing transcription, or free (Pf) thanks to IPTG binding to the repressor. We assume that one IPTG molecule binds with one repressor molecule, freeing the promoter and restoring RNA polymerase binding capacity. The real mechanism of promoter Plac is more complex, as described in [1], but this simplification is sufficient for our model.</p> | ||
− | + | <img src=""> | |
− | + | ||
− | + | ||
− | + | ||
− | + | ||
<p>The transport of IPTG from outside the cell to cytoplasm is considered to be only due to free diffusion through the membrane by two first order reaction with the same kinetic constant.<p> | <p>The transport of IPTG from outside the cell to cytoplasm is considered to be only due to free diffusion through the membrane by two first order reaction with the same kinetic constant.<p> | ||
+ | <img src=""> | ||
+ | <p>IPTG is not considered to be degraded neither in the cytoplasm nor in the medium.</p> | ||
+ | <p>For the TEV and NGF transcription, we use a first-order reaction where the rate of mRNA production (m) depends on the concentration of the free promoter (Pf).</p> | ||
+ | <img src=""> | ||
+ | <p>For the TEV and NGF translation, we first consider binding of ribosomes to ribosome binding site (the same association constant is used since the r.b.s. are the same), and then translation rate is proportional to the protein length. Since TEV and NGF have approximately the length, we consider only one translation rate β.</p> | ||
+ | <img src=""> | ||
+ | <p>Even though it still has an export peptide, TEV is assumed to be functional in the cytoplasm (although less functional than if it had no export peptide). Since NGF has TEV cleaving site between the coding sequence and the export peptide, a fraction of NGF is cleaved inside the cytoplasm and thus cannot be secreted. We use a simple model to simulate TEV kinetics: TEV recognizes the signal sequence ENLYFQ, bind to its substrate and then cleave the export peptide. This process can thus be modeled by the following equations:</p> | ||
+ | <img src=""> | ||
+ | <p>K1, k-1 and k2 are taken lower than constants found in literature, in order to model the fact that TEV still has its signal peptide and is consequently less functional than usually.</p> | ||
</div> | </div> | ||
− | <div class="block | + | <div class="block title"> |
− | + | <h3>2. NGF and TEV secretion to the medium</h3> | |
</div> | </div> | ||
<div class="block full"> | <div class="block full"> | ||
− | <p> | + | <p>The transport of NGF and TEV with their export signal peptide from inside the cell to the medium is assumed to follow Michaelis-Menten enzymatic kinetics in which the transporter channel (composed of HlyB in the inner membrane, bound to HlyD and recruiting TolC in the outer membrane) plays the role of the enzyme and intracellular protein the role of the substrate.</p> |
− | <p> | + | <p>Each protein (NGF and TEV) via its export signal peptide HlyA can bind to the HlyB-HlyD complex pore, forming a protein-transporter complex (NGFt or TEVt). Translocation correspond to the dissociation of this complex, resulting in restoring a free transporter and secreting NGF or TEV in the medium (NGFum and TEVm), which stand for the products.</p> |
+ | <img src=""> | ||
</div> | </div> | ||
− | <div class="block | + | <div class="block title"> |
− | + | <h3>3. Including growth rate</h3> | |
</div> | </div> | ||
<div class="block full"> | <div class="block full"> | ||
− | <p> | + | <p>This model stands for one bacterial cell, but for our model to best fit what our future system will look like, we need to integrate the growth rate of our bacteria within the microchannel chip well. Therefore, we measured DO of a culture of our bacteria, in stationary growth phase, in order to fit a growth equation.</p> |
+ | <p>For the growth rate of our transformed bacteria we use the equation fitted to the determined values of OD600. </p> | ||
+ | <img src=""> | ||
</div> | </div> | ||
− | <div class="block | + | <div class="block title"> |
− | + | <h3>4. NGF folding and export peptide cleavage by TEV</h3> | |
</div> | </div> | ||
<div class="block full"> | <div class="block full"> | ||
− | <p> | + | <p>Once in the medium, both NGF and TEV are still bound to the export signal peptide HlyA. We assume there is a very small amount of functional TEV, that is sufficient to cleave TEV signal peptide, producing more functional TEV.</p> |
+ | <p>As for the transporter, we use a simple model in which TEV recognizes the signal sequence ENLYFQ, bind to its substrate (which can be either NGF with its export peptide or TEV with its export peptide) and then cleave the export peptide. This process can thus be modeled by the following equations:</p> | ||
+ | <img src=""> | ||
</div> | </div> | ||
− | <div class="block | + | <div class="block title"> |
− | + | <h3>5. mRNA and protein degradation</h3> | |
</div> | </div> | ||
<div class="block full"> | <div class="block full"> | ||
− | <p> | + | <p>Finally, in cytoplasm and in the medium, mRNA and protein are degraded and all degradations are assumed to follow first-order kinetic reactions.</p> |
+ | <img src=""> | ||
+ | <h6>MODEL PARAMETRISATION</h6> | ||
+ | <p>From these equations, we obtained a system of differential equations mostly based on mass action kinetics (GET IT HERE). We numerically solveD the ordinary differential equations system using Euler method implemented in Python. The constants we used were mainly determined from literature AND are given in table …</p> | ||
</div> | </div> | ||
</div> | </div> |
Revision as of 16:36, 6 September 2018
General introduction
The aim of our mathematical model is to simulate the growth of neurons towards our biofilm in response of the presence of Nerve Growth Factor (NGF). Nerve growth factor is one of a group of small proteins called neurotrophins that are re-sponsible for the development of new neurons, and for the health and maintenance of mature ones. We created a determin-istic model to help the wetlab establish the optimal concen-tration gradients of NGF needed for the regrowth of the nerves. NGF concentration and concentration gradient are key parameters affecting the growth rate and direction of neu-rites. Neurites growth have shown to be NGF dose-dependent: if NGF concentration si too low or too high, the growth rate is attenuated. In order to visualize the results of the model on a microfluidic chip we used MATLAB, App Designer, Python, Gmsh and FreeFem. This is an important part of our project since it creates the link between the wetlab and drylab.
We divided our model in three parts:
- Production of NGF by the E. coli genetically modified
- Simulation of the diffusion of NGF in a given environment
- Neurons growth in the presence of NGF
Context of our model
Our project aims at creating a biofilm composed of genetically modified E. coli able to release a neurotrophic factor: NGF. It helps to accelerate the connection between the neurons and the implant of the prothesis; hence aiming at connecting directly the prothesis amputee’s neurons. This will enable the patient to have a more instinctive control of his prothesis device. The nerves will be guided towards a conductive membrane surrounding our genetically modified biofilm. This membrane will then pass the neural signal of the regenerated nerves towards the electronic chip of the implant through wires. It will allow the patient to have a more instinctive and natural control than any other current prosthesis, and a reduced reeducation time.
The aim of the wetllab is to test the biofilm on a microfluidic chip as a proof of concept. The chip is composed of two compartments: one made of the E. coli genetically modified to produce NGF and the other one of neurons. Micro canals link the two compartments in the middle of the chip, allowing the diffusion of NGF and the growth of the neurites. Our model will hence be established on a micro-fluidic chip shape in order to share our results with the wetlab and indicate them the optimal concentration of NGF needed according to their model.
We introduce different parameters in order to create our model :
g | Length of the neurite outgrowth |
dg/dt
|
Neurite outgrowth rate |
u(x,t) | Concentration of NGF at the position x and time t |
du/dt
|
NGF concentration gradient at the position x and time t |
Cdiff | Diffusion coefficient of NGF |
K | Gradient factor (growth rate of the neurite under the stimulation of the NGF concentration gradient) |
Gθ | Baseline growth rate (neurite growth rate in absence of NGF concentration gradient) |
L | Length of the conduit |
NGF Production by genetically modified E. coli
NGF diffusion simultation in a given environment
Neurons growth in the presence of NGF
References
[1] Defining the concentration gradient of nerve growth factor for guided neurite outgrowth, XCao M.SShoichet, March 2001
[2] Immobilized Concentration Gradients of Neurotrophic Factors Guide Neurite Outgrowth of Primary Neurons in Macroporous Scaffolds, Moore K, MacSween M, Shoichet M, feb 2006
[3] Mathematical Modeling of Guided Neurite Extension in an Engineered Conduit with Multiple Concentration Gradients of Nerve Growth Factor (NGF), Tse TH, Chan BP, Chan CM, Lam J, sep 2007
[4] Mathematical modelling of multispecies biofilms for wastewater treatment, Maria Rosaria Mattei, november 2005